Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study

Raymond K. Mulhern, James L. Kepner, Patrick R. Thomas, F. Daniel Armstrong, Henry S. Friedman, Larry E. Kun

Research output: Contribution to journalArticle

304 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to test the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for low-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and elder (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity was obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children treated for medulloblastoma experienced less severe neuropsychologic toxicity when treated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation.

Original languageEnglish (US)
Pages (from-to)1723-1728
Number of pages6
JournalJournal of Clinical Oncology
Volume16
Issue number5
DOIs
StatePublished - Jan 1 1998

Fingerprint

Craniospinal Irradiation
Medulloblastoma
Survivors
Pediatrics
Cranial Irradiation
Intelligence
Neuropsychological Tests
Cognition
Reading
Age Groups
Quality of Life
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation : A Pediatric Oncology Group study. / Mulhern, Raymond K.; Kepner, James L.; Thomas, Patrick R.; Armstrong, F. Daniel; Friedman, Henry S.; Kun, Larry E.

In: Journal of Clinical Oncology, Vol. 16, No. 5, 01.01.1998, p. 1723-1728.

Research output: Contribution to journalArticle

Mulhern, Raymond K. ; Kepner, James L. ; Thomas, Patrick R. ; Armstrong, F. Daniel ; Friedman, Henry S. ; Kun, Larry E. / Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation : A Pediatric Oncology Group study. In: Journal of Clinical Oncology. 1998 ; Vol. 16, No. 5. pp. 1723-1728.
@article{5978051c50b84904a720f005b575142b,
title = "Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study",
abstract = "Purpose: The purpose of this study was to test the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for low-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and elder (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity was obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children treated for medulloblastoma experienced less severe neuropsychologic toxicity when treated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation.",
author = "Mulhern, {Raymond K.} and Kepner, {James L.} and Thomas, {Patrick R.} and Armstrong, {F. Daniel} and Friedman, {Henry S.} and Kun, {Larry E.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1200/JCO.1998.16.5.1723",
language = "English (US)",
volume = "16",
pages = "1723--1728",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

TY - JOUR

T1 - Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation

T2 - A Pediatric Oncology Group study

AU - Mulhern, Raymond K.

AU - Kepner, James L.

AU - Thomas, Patrick R.

AU - Armstrong, F. Daniel

AU - Friedman, Henry S.

AU - Kun, Larry E.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Purpose: The purpose of this study was to test the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for low-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and elder (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity was obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children treated for medulloblastoma experienced less severe neuropsychologic toxicity when treated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation.

AB - Purpose: The purpose of this study was to test the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for low-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and elder (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity was obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children treated for medulloblastoma experienced less severe neuropsychologic toxicity when treated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation.

UR - http://www.scopus.com/inward/record.url?scp=0031804128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031804128&partnerID=8YFLogxK

U2 - 10.1200/JCO.1998.16.5.1723

DO - 10.1200/JCO.1998.16.5.1723

M3 - Article

C2 - 9586884

AN - SCOPUS:0031804128

VL - 16

SP - 1723

EP - 1728

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -